PET/CT Follow up for Head and Neck Squamous Cell Carcinoma

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRigshospitalet, Denmark

About this trial

PET/CT follow up for Head and Neck Squamous Cell Carcinoma The following is a presentation of a prospective protocol, named PET/CT follow up for Head and Neck Squamous Cell Carcinoma (PET Follow), including patients who have completed radiotherapy treatment for squamous cell carcinoma of the head and neck (HNSCC).

The purpose of this study is to investigate the diagnostic performance of 18F-fluorodeoxy-D-glucose (FDG) Positron Emission Tomography/ Computed Tomography (PET/CT) in patients with HNSCC after curative intended treatment.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Informed consent

Age above 18

Completed curative treatment for HNSCC of the oral cavity, nasopharynx, oropharynx, hypopharynx or larynx

Disqualifiers

Patient refusal

Patients with clinical N0 neck

Patients who had neck dissections prior to radiotherapy

Patients who are clinical inoperable for any reason

Trial design

Design model

Single group

Treatments tested in this trial

  • Neck dissection

    Procedure/Surgery

    Based on PET/CT scan patients will undergo neck dissection.

Treatment groups

600 Participants
are divided into 1 treatment group
Group A: SurgeryOther 1 intervention

Trial outcomes

Primary outcomes

1

Number of patients with malignant lymph nodes

Number of lymph nodes with vital tumor cells

Time frame
2 weeks

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.